pharmaphorum.com
Open in
urlscan Pro
134.213.29.200
Public Scan
Submitted URL: http://pharmaphorum.com/
Effective URL: https://pharmaphorum.com/
Submission: On May 20 via api from GB — Scanned from GB
Effective URL: https://pharmaphorum.com/
Submission: On May 20 via api from GB — Scanned from GB
Form analysis 3 forms found in the DOM
GET /
<form id="searchform" class="searchform" action="/" method="get">
<div class="col50 label">
<label class="screen-reader-text" for="s">Search</label>
</div>
<div class="col50 close">
<a href="javascript:;" class="closeSea">Close</a>
</div>
<div class="col100">
<input id="s" name="s" type="text">
<input id="searchbutton" alt="Submit Form" height="31" src="/wp-content/themes/magazine-child/images/searchHeader.png" type="image">
</div>
</form>Name: subscription — POST https://pharmaphorum.com/index.php?wp_nlm=subscription
<form method="POST" name="subscription" action="https://pharmaphorum.com/index.php?wp_nlm=subscription">
<input name="xyz_em_name" type="hidden">
<!--<input name="xyz_em_email" type="text" placeholder="Enter your email address" />-->
<!--<input id="submit_em" class="buttonWidget" type="submit"
value="Subscribe free"
onclick="javascript: if(!verify_fields()) return false; " />-->
<input id="submit_em" class="buttonWidget" type="submit" value="Subscribe free" onclick="javascript: window.open("http://eepurl.com/gxhZY1", "_blank"); return false;">
</form>Name: login — POST https://pharmaphorum.com/wp-login.php
<form name="login" id="login" action="https://pharmaphorum.com/wp-login.php" method="post">
<p class="login-username">
<label for="user_login">Username or Email Address</label>
<input type="text" name="log" id="user_login" class="input" value="" size="20">
</p>
<p class="login-password">
<label for="user_pass">Password</label>
<input type="password" name="pwd" id="user_pass" class="input" value="" size="20">
</p>
<p class="login-remember"><label><input name="rememberme" type="checkbox" id="rememberme" value="forever"> Remember Me</label></p>
<p class="login-submit">
<input type="submit" name="wp-submit" id="wp-submit" class="button button-primary" value="Log In">
<input type="hidden" name="redirect_to" value="https://pharmaphorum.com/">
</p>
</form>Text Content
Menu Close Subscribe Sign In Why register? * Home * Views & analysis * Digital Debates * White Papers * Podcasts & Videos * Partner content * News * Events * Find an event * Live event coverage * Deep Dive * Sales and marketing * News * Views & Analysis * Debates & Insight * Partner Content * Digital * News * Views & Analysis * Debates & Insight * Partner Content * Market Access * News * Views & Analysis * Debates & Insight * Partner Content * Oncology * News * Views & Analysis * Debates & Insight * Partner Content * Patients * News * Views & Analysis * Debates & Insight * Partner Content * R&D * News * Views & Analysis * Debates & Insight * Partner Content * Spotlight On * Frontiers Health 2021 * The Future of Generics * Advertise Search Search Close TRENDING EU imposes Horizon funding block on UK scientists Bayer bails on $670m CAR-T partnership with Atara Sidekick and Pfizer prep launch of DTx for atopic dermatitis Coalition aims to improve cancer drug access in poorer nations Conducting successful commercial research in a primary care setting EU imposes Horizon funding block on UK scientists Bayer bails on $670m CAR-T partnership with Atara in News EU IMPOSES HORIZON FUNDING BLOCK ON UK SCIENTISTS May 20, 2022 Share X EU imposes Horizon funding block on UK scientists https://pharmaphorum.com/news/eu-imposes-horizon-funding-block-on-uk-scientists/ UK scientists are being denied from joining the €95 billion Horizon research funding programme as a dispute over in News BAYER BAILS ON $670M CAR-T PARTNERSHIP WITH ATARA May 20, 2022 Share X Bayer bails on $670m CAR-T partnership with Atara https://pharmaphorum.com/news/bayer-bails-on-670m-car-t-partnership-with-atara/ In February, Atara Biotherapeutics paused enrolment into a trial of a CAR-T cell therapy for mesothelioma after a in News SIDEKICK AND PFIZER PREP LAUNCH OF DTX FOR ATOPIC DERMATITIS May 20, 2022 Share X Sidekick and Pfizer prep launch of DTx for atopic dermatitis https://pharmaphorum.com/news/sidekick-and-pfizer-prep-launch-of-dtx-for-atopic-dermatitis/ A long-running partnership between digital therapeutics (DTx) developer Sidekick Health and Pfizer has resulted in a new app in News COALITION AIMS TO IMPROVE CANCER DRUG ACCESS IN POORER NATIONS May 20, 2022 Share X Coalition aims to improve cancer drug access in poorer nations https://pharmaphorum.com/news/coalition-aims-to-improve-cancer-drug-access-in-poorer-nations/ Several of the top pharmaceutical companies have joined a new coalition that aims to improve access to cancer in Patients CONDUCTING SUCCESSFUL COMMERCIAL RESEARCH IN A PRIMARY CARE SETTING May 20, 2022 Share X Conducting successful commercial research in a primary care setting https://pharmaphorum.com/patients/conducting-successful-commercial-research-in-a-primary-care-setting/ The primary care setting has garnered significant attention from industry stakeholders due to its promise in commercial research. in News EU IMPOSES HORIZON FUNDING BLOCK ON UK SCIENTISTS May 20, 2022 Share X EU imposes Horizon funding block on UK scientists https://pharmaphorum.com/news/eu-imposes-horizon-funding-block-on-uk-scientists/ UK scientists are being denied from joining the €95 billion Horizon research funding programme as a dispute over in News BAYER BAILS ON $670M CAR-T PARTNERSHIP WITH ATARA May 20, 2022 Share X Bayer bails on $670m CAR-T partnership with Atara https://pharmaphorum.com/news/bayer-bails-on-670m-car-t-partnership-with-atara/ In February, Atara Biotherapeutics paused enrolment into a trial of a CAR-T cell therapy for mesothelioma after a LATEST NEWS COALITION AIMS TO IMPROVE CANCER DRUG ACCESS IN POORER NATIONS Several of the top pharmaceutical companies have joined a new coalition that aims to improve access to cancer Share X Coalition aims to improve cancer drug access in poorer nations https://pharmaphorum.com/news/coalition-aims-to-improve-cancer-drug-access-in-poorer-nations/ EU IMPOSES HORIZON FUNDING BLOCK ON UK SCIENTISTS UK scientists are being denied from joining the €95 billion Horizon research funding programme as a dispute over Share X EU imposes Horizon funding block on UK scientists https://pharmaphorum.com/news/eu-imposes-horizon-funding-block-on-uk-scientists/ SLEEPIO APP FOR INSOMNIA BACKED BY NICE After a non-committal appraisal of Big Health’s Sleepio app for insomnia last November in draft guidance from NICE, Share X Sleepio app for insomnia backed by NICE https://pharmaphorum.com/news/sleepio-app-for-insomnia-backed-by-nice/ See all VIEWS & ANALYSIS CONDUCTING SUCCESSFUL COMMERCIAL RESEARCH IN A PRIMARY CARE SETTING The primary care setting has garnered significant attention from industry stakeholders due to its promise in commercial research. Share X Conducting successful commercial research in a primary care setting https://pharmaphorum.com/patients/conducting-successful-commercial-research-in-a-primary-care-setting/ ON CLINICAL TRIALS DAY, CVS SHARES LESSONS LEARNED FROM ONE YEAR PROVIDING TRIAL SERVICES CVS Health has come a long way from its humble beginnings as a health and beauty products store Share X On Clinical Trials Day, CVS shares lessons learned from one year providing trial services https://pharmaphorum.com/r-d/on-clinical-trials-day-cvs-shares-lessons-learned-from-one-year-providing-trial-services/ HOW PHARMA CAN SPUR INNOVATION AND PROMOTE HEALTH EQUITY IN MENTAL HEALTH: THE PHARMAPHORUM PODCAST In the newest episode of the pharmaphorum podcast, editor in chief Jonah Comstock speaks with Mohammed Issa, vice Share X How pharma can spur innovation and promote health equity in mental health: the pharmaphorum podcast https://pharmaphorum.com/podcast/how-pharma-can-spur-innovation-and-promote-health-equity-in-mental-health/ See all DEEP DIVE MAGAZINE DEEP DIVE: MARKET ACCESS For life science companies around the world, enabling faster access to innovative drugs and therapies is a complicated Share X Deep Dive: Market Access https://pharmaphorum.com/market-access-2/deep-dive-market-access-2022/ EMERGING TECHNOLOGIES THAT ARE CHANGING THE WAY HEALTHCARE IS DELIVERED IN 2022 Wherever you consider the medical industry, you will find several new technologies being used to make new medicines, Share X Emerging technologies that are changing the way healthcare is delivered in 2022 https://pharmaphorum.com/r-d/emerging-technologies-that-are-changing-the-way-healthcare-is-delivered-in-2022/ INSIDE THE CHANGING TIDES OF LIFE SCIENCE RESEARCH Astellas Pharma chief medical officer Bernhardt Zeiher talks about the evolution of R&D in life sciences Research and Share X Inside the changing tides of life science research https://pharmaphorum.com/r-d/inside-the-changing-tides-of-life-science-research/ See all WEBINARS MEDICAL INFORMATICS AND RARE DISEASE: A BRIDGE BETWEEN TWO WORLDS Share X Medical Informatics and Rare Disease: a bridge between two worlds https://pharmaphorum.com/webinars/medical-informatics-bridge-between-two-worlds-iqvia/ ICSS – AN OPPORTUNITY TO IMPROVE PATIENT & MARKET ACCESS AT A LOCAL LEVEL Share X ICSs – an opportunity to improve Patient & Market Access at a local level https://pharmaphorum.com/webinars/integrated-care-systems-opportunity-to-improve-patient-market-access/ IS YOUR DIGITAL COMMUNICATION STRATEGY UP TO PAR? Share X Is your digital communication strategy up to par? https://pharmaphorum.com/webinars/is-your-digital-communication-strategy-up-to-par/ See all WHITE PAPERS ACHIEVING DIVERSITY, EQUITY AND INCLUSION IN CLINICAL TRIALS Making sure clinical trials are diverse and representative of the populations they’re studying isn’t just the right thing Share X Achieving diversity, equity and inclusion in clinical trials https://pharmaphorum.com/r-d/achieving-diversity-equity-and-inclusion-in-clinical-trials/ HOW TO IDENTIFY AND ENGAGE WITH DIGITAL OPINION LEADERS The industry has long sought the insight and advice of revered, influential figures. Typically, these key opinion leaders Share X How to identify and engage with digital opinion leaders https://pharmaphorum.com/whitepapers/how-to-identify-and-engage-with-digital-opinion-leaders/ 5 BEST PRACTICES FOR IMPROVING PATIENT ENGAGEMENT Life science companies invest a significant number of resources to engage physicians and patient advocates. However, companies often Share X 5 best practices for improving patient engagement https://pharmaphorum.com/whitepapers/5-best-practices-improving-patient-engagement/ See all VIDEO HOW PHARMA CAN SPUR INNOVATION AND PROMOTE HEALTH EQUITY IN MENTAL HEALTH: THE PHARMAPHORUM PODCAST Share X How pharma can spur innovation and promote health equity in mental health: the pharmaphorum podcast https://pharmaphorum.com/podcast/how-pharma-can-spur-innovation-and-promote-health-equity-in-mental-health/ INNOVATIVE SOLUTIONS TO THE DRUG PRICING CRISIS: THE PHARMAPHORUM PODCAST Share X Innovative solutions to the drug pricing crisis: the pharmaphorum podcast https://pharmaphorum.com/podcast/innovative-solutions-to-the-drug-pricing-crisis-the-pharmaphorum-podcast/ HEALTH INNOVATORS – AMY BUCHER Share X Health Innovators – Amy Bucher https://pharmaphorum.com/patients/health-innovators-amy-bucher/ See all PARTNER CONTENT PRESS RELEASES KOL VALIDATION: AN OPPORTUNITY TO BENCHMARK MINDSET Share X KOL Validation: An Opportunity To Benchmark Mindset https://pharmaphorum.com/partner-content/kol-validation-an-opportunity-to-benchmark-mindset/ CONTENT FACTORY 24/7: VISEVEN ADDS A CENTER OF EXCELLENCE IN INDIA TO PROVIDE AROUND-THE-CLOCK GLOBAL SUPPORT FOR ITS CLIENTS Share X Content Factory 24/7: Viseven adds a Center of Excellence in India to provide around-the-clock global support for its clients https://pharmaphorum.com/partner-content/content-factory-24-7-viseven-adds-a-center-of-excellence-in-india-to-provide-around-the-clock-global-support-for-its-clients/ 4 REASONS WHY YOU SHOULDN’T IGNORE CDISC DATA STANDARDS Share X 4 Reasons Why You Shouldn’t Ignore CDISC Data Standards https://pharmaphorum.com/partner-content/4-reasons-why-you-shouldnt-ignore-cdisc-data-standards/ HOW TO PROVIDE VALUE THAT BENEFITS PATIENTS (AND YOUR BRAND) Share X How to Provide Value that Benefits Patients (and Your Brand) https://pharmaphorum.com/partner-content/how-to-provide-value-that-benefits-patients-and-your-brand/ See all APPOINTMENTS AXON HIRES A GLOBAL HEALTHCARE INSIGHTS AND STRATEGY LEAD Share X AXON hires a Global Healthcare Insights and Strategy Lead https://pharmaphorum.com/partner-content/axon-hires-a-global-healthcare-insights-and-strategy-lead/ PERFORMANCE-IO HIRES LONNEKE FESKENS TO LEAD EUROPE Share X Performance-io hires Lonneke Feskens to lead Europe https://pharmaphorum.com/partner-content/performance-io-hires-lonneke-feskens-to-lead-europe/ See all GET IN-DEPTH NEWS, OPINIONS AND FEATURES ON PHARMA AND HEALTHCARE SENT STRAIGHT TO YOUR INBOX FEATURED CONTENT HOW TO IMPROVE PAYER ENGAGEMENT WITH TAILORED VALUE COMMUNICATION HOW WILL NICE FARE IN A POST-BREXIT WORLD? HOW TO IMPROVE PAYER ENGAGEMENT WITH TAILORED VALUE COMMUNICATION HOW WILL NICE FARE IN A POST-BREXIT WORLD? HOW TO IMPROVE PAYER ENGAGEMENT WITH TAILORED VALUE COMMUNICATION HOW WILL NICE FARE IN A POST-BREXIT WORLD? previous next EVENTS CELL & GENE THERAPY 2018 PATIENT ENGAGEMENT EVENT - A REAL WORLD SNAPSHOT, BEYOND THE TALK MAPS 2018 EMEA ANNUAL MEETING CELL & GENE THERAPY 2018 PATIENT ENGAGEMENT EVENT - A REAL WORLD SNAPSHOT, BEYOND THE TALK MAPS 2018 EMEA ANNUAL MEETING CELL & GENE THERAPY 2018 previous next Post an event See all MOST POPULAR * Most Viewed * Moderna's HIV vaccine prepped for trials in Africa * Merck snaps up cancer drug from China's Kelun in $1.4bn deal * Digital health body publishes best practice guide for DTx developers * AstraZeneca buys into startup RQ Bio's COVID antibodies * Large UK study suggests vaccination helps treat long COVID See all TWEETS FROM @PHARMAPHORUM Back to Top * Advertise * pharmaphorum connect * * Contribute * Work for pharmaphorum * * About us * Contact us * Privacy policy * Terms & conditions * Cookie Policy * * * * * * The rights of trade mark owners are acknowledged. pharmaphorum media limited Website and content copyright © 2009-2022, pharmaphorum media limited or its licensors; all rights reserved. © 2022 Powered by WordPress • Themify WordPress Themes LOGIN Username or Email Address Password Remember Me Lost your password? CONTINUE TO SITE > X Close in 10 seconds Pharmaphorum.com Notifications Spread the message. Stop the virus. HandsWash often ElbowCough into FaceDon't touch SpaceAvoid crowds HomeStay inside 1,511,104Confirmed 328,661Recovered